ARCHIVES

NCI Staff Discusses New Guidelines for Core Grant Reviews, Comprehensiveness

This article is from The Cancer Letter archive.

Vol. 18 No. 30 | July 24, 1992

Download PDF Visit The Full Archive

Related Articles

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

HHS Carcinogen Guidelines Draft

June 6, 1980

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005